• Lactic Acidosis Adverse Drug Reaction Reporting Aspect Evaluation of Hepatitis B Treatment Using Kor...

• Lee Sun-Min

• Kwon Min-Ji, Lee Soo-Young, Kim Jong-Yoon

• Journal of Pharmacoepidemiology and Risk Management   2022  Volume.14  No.2 144 ~ 148

• Case Analysis in Drug Approval by FDA/EMA Using Real-World Data/Real-World Evidence

• Song Jae-Hwan

• Kim Jun-Hyuck, Park So-Hee, Kim Ju-Hwan, Noh Yun-Ha, Sung Hi-Gin, Shin Ju-Young

• Journal of Pharmacoepidemiology and Risk Management   2022  Volume.14  No.2 133 ~ 143

• Update of Drug-induced Kidney Injury

• Lee Ha-Jeong

• Journal of Pharmacoepidemiology and Risk Management   2022  Volume.14  No.2 125 ~ 132

• Introducing Patient Safety Activities in Canada: Focused on Medication Incidents and Preventions

• Kim Su-Jin

• Yang Ji-Yun, Jung Sun-Young, Lim Jae-Young, Yoon Hae-Jin, Park Hye-Kyung, Lee Mo-Se

• Journal of Pharmacoepidemiology and Risk Management   2022  Volume.14  No.2 114 ~ 124

• Recent Change of the Etiology of Drug Induced Anaphylaxis in a Korean Tertiary Care H ospital

• Park Jung-Won

• Journal of Pharmacoepidemiology and Risk Management   2022  Volume.14  No.2 109 ~ 113

• Systematic Review for Remdesivir Use in Pediatric Patients under 3.5 kg with COVID-19

• Cho Won-Bean

• Lee Na-Yoon, Ah Young-Mi

• Journal of Pharmacoepidemiology and Risk Management   2022  Volume.14  No.2 101 ~ 108